# Safety and Efficacy of Very Short DAPT in Older Patients Undergoing PCI

Study · id `cardio:ct-nct07164859` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07164859](<https://clinicaltrials.gov/study/NCT07164859>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07164859

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1700 participants.

## Technical summary

Registry record NCT07164859. Randomized; single masking; primary purpose treatment. Start 2026-03-03 (actual); primary completion 2029-10 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 1700 participants (planned count; ClinicalTrials.gov record NCT07164859, source copy `cardio:ctgov-nct07164859-2026-11-03`, retrieved 2026-11-18)
- Started: 2026-03-03 (actual) (ClinicalTrials.gov record NCT07164859, source copy `cardio:ctgov-nct07164859-2026-11-03`, retrieved 2026-11-18)
- Primary completion: 2029-10 (anticipated) (ClinicalTrials.gov record NCT07164859, source copy `cardio:ctgov-nct07164859-2026-11-03`, retrieved 2026-11-18)
- Completion: 2029-10 (anticipated) (ClinicalTrials.gov record NCT07164859, source copy `cardio:ctgov-nct07164859-2026-11-03`, retrieved 2026-11-18)
- Countries: France (ClinicalTrials.gov record NCT07164859, source copy `cardio:ctgov-nct07164859-2026-11-03`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07164859-2026-11-03`, retrieved 2026-11-18)

## The registry's words

- Brief title: Safety and Efficacy of Very Short DAPT in Older Patients Undergoing PCI
- Acronym: SOLOPCI
- Condition: Coronary Artery Disease (CAD)
- Condition: Percutaneous Coronary Intervention (PCI)
- Condition: Antiplatelet Therapy
- Condition: Elderly (People Aged 65 or More)
- Intervention (Drug): short dual antiplatelet therapy (DAPT) duration
- Intervention (Drug): Standard DAPT duration
- Lead sponsor: Vincent ROULE
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)

## Provenance

Content hash: a2bcf358698f8b3ca5e398c525e33edda753ae27bc31a123ff04922f2f415ce5
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
